Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the next badge(s):
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Medicine, Vagelos College of Physicians and Surgeons
… → 1982
Bachelor of Science, Princeton University
… → 1978
Research Strategic Pillar Keywords
- Brain Health
- Specialized Health
- Metabolic Health
- Life Span Health
- Infectious/ Immunological Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Proyecto ya con garantías
Abdool Karim, S. (PI) & Abrams, E. J. (PI)
Universidad Argentina de la Empresa
Project: Other project
-
Proyecto principal
Abdool Karim, S. (PI) & Abrams, E. J. (CoPI)
10/14/21 → 11/12/22
Project: Research project
-
HIV research with GSU
Abrams, E. J. (PI), Abdool Karim, Q. (PI) & Abdool Karim, S. (PI)
2/12/20 → 3/16/22
Project: Research project
-
Assessing the safety and pharmacokinetics of the monoclonal antibodies
Abdool Karim, S. (PI), Abdool Karim, Q. (CoPI), Abraido-Lanza, A. F. (PI), Abrams, E. J. (CoPI), Masera, O. (Research assistant) & Abiola, S. (Research assistant)
2/4/20 → 3/19/22
Project: Research project
-
Lesotho PHIT Partnership: A Proposal to Strengthen Health Systems and Support Primary Care and District Health Systems
Abrams, E. J. (PI) & Ntumy, R. (PI)
Doris Duke Charitable Foundation
1/1/08 → 12/31/11
Project: Research project
-
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
ODYSSEY Trial Team, Oct 2023, In: The Lancet Child and Adolescent Health. 7, 10, p. 718-727 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pre-exposure prophylaxis uptake concerns in the Democratic Republic of the Congo: Key population and healthcare workers perspectives
Shen, Y., Franks, J., Reidy, W., Olsen, H., Wang, C., Mushimbele, N., Mazala, R. T., Tchissambou, T., Malele, F., Kilundu, A., Bingham, T., Djomand, G., Mukinda, E., Ewetola, R., Abrams, E. J. & Teasdale, C. A., Nov 2023, In: PLoS One. 18, 11 NOVEMBER, e0280977.Research output: Contribution to journal › Article › peer-review
Open Access -
Advancing the prevention and treatment of HIV in children: priorities for research and development
PADO-HIV 5 participants, Sept 2022, In: The Lancet HIV. 9, 9, p. e658-e666Research output: Contribution to journal › Review article › peer-review
19 Citations (Scopus) -
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
ODYSSEY Trial Team, Sept 2022, In: The Lancet HIV. 9, 9, p. e627-e637Research output: Contribution to journal › Article › peer-review
Open Access16 Citations (Scopus) -
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
ODYSSEY Trial Team, Sept 2022, In: The Lancet HIV. 9, 9, p. e638-e648Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus)